The activity of four fluoroquinolones against strains of Pseudomonas aeruginosa with a different sensitivity pattern to ceftazidime and imipenem;Actividad de cuatro fluoroquinolonas frente a cepas de Pseudomonas aeruginosa con diferente patrón de sensibilidad a ceftazidima e imipenem

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 19, Issue 9, 2001, Pages 432-434

  Pascual, Álvaro ^a   Joyanes, Providencia ^a   Martínez Martínez, Luis ^a   Conejo, María Del Carmen ^a   Hernández, Gonzalo ^b   Chaves, José ^b   Perea, Evelio J ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b Depto de Investigacion y Desarrollo   (Spain)

Author keywords

Clinafloxacin; P. aeruginosa; Resistance

Indexed keywords

CATION; CEFTAZIDIME; CIPROFLOXACIN; CLINAFLOXACIN; IMIPENEM; NORFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DILUTION; DRUG ACTIVITY; EVALUATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

EID: 0035218341     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0213-005X(01)72687-0     Document Type: Article

References (13)

1. Hancock REW. Resistance mechanism in Pseudomonas aeruginosa and other nonfermentative Gram-negative bacteria. Clin Microbiol Dis 1998; 27(supp 1): S93-S99.
2. Cambau E, Perani E, Dib C, Petinon C, Trias J, Jarlier V. Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem. Antimicrob Agents Chemohter 1995; 39: 2.248-2.252.
3. Kohler T, Pechere JC, Plesiat P. Bacterial antibiotic efflux systems of medical importance. Cell Mol Life Sci 1999; 56: 771-778.
4. Xian-Zhi L, Zhang L, Poole K. Interplay between the MexA-MexB-OprM multidurg efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa. J Antimicrob Chemother 2000; 45: 433-436.
5. Ziha-Zaifi I, Lianes C, Köler T, Pechere JC, Plesiat P. In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB OprM. Antimicrob Agents Chemother 1999; 43: 287-291.
6. Lee A, Mao W, Warren MS, Mistry A, Hoshino K, Okumura R, et al. Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance. J Bacteriol 2000; 182: 3.142-3.150.
7. Schmitz FJ, Fluit AC, Milatovic D, Verhoef J, Heinz HP, Brisse S. In vitro potency of moxifloxacin, clinafloxacin and sitafloxacin against 248 genetically defined clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 2000; 46: 109-113.
8. Pascual A, López-Hernández I, Martínez-Martínez L, Perea EJ. In vitro susceptibilities of multiresistant strains of Acinetobacter baumannii to eight quinolones. J Antimicrob Chemother 1997; 40: 140-142.
9. Hernández JR, Martínez-Martínez L, Pascual A, Suárez AI, Perea EJ. Trends in the susceptibilities of Proteus mirabilis isolates to quinolones. J Antimicrob Chemother 2000; 45: 407-408.
10. Martínez-Martínez L, Joyanes P, Pascual A, Terrero E, Perea EJ. Activity of eight fluorquinolones against enterococci. Clin Microbiol Infect 1997; 3: 497-499.
11. Martínez-Martínez L, Suárez AI, Ortega MC, Perea EJ. Comparative in vitro activities of new quinolones against coryneform bacteria. Antimicrob Agents Chemother 1994; 38: 1.439-1.441.
12. Joyanes P, Mazza B, Martínez L, López-López G, Pascual A. Actividad de ocho fluoroquinolonas frente a biocapas de Escherichia coli y Pseudomonas aeruginosa sobre sondas urinarias de látex siliconizado. Enferm Infecc Microbiol Clin 2000; 18: 27-40.
13. Lomovskaya O, Warren MS, Lee A, Galazzo J, Fronko R, Lee M, et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 2001; 45: 105-116.